Abiopharma

New Form 144 - Apellis Pharmaceuticals, Inc. Filed: 2025-07-16 AccNo: 0001959173-25-004609 Size: 5 KB

New Form 144 - MANNKIND CORP Filed: 2025-07-16 AccNo: 0001950047-25-005056 Size: 6 KB

New Form 4 - Shattuck Labs, Inc. Filed: 2025-07-16 AccNo: 0000950170-25-096254 Size: 5 KB

TransMedics to Report Second Quarter 2025 Financial Results on July 30, 2025

Pulse Biosciences Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

New Form 4 - Inspire Medical Systems, Inc. Filed: 2025-07-16 AccNo: 0001104659-25-068329 Size: 4 KB

New Form 144 - Vor Biopharma Inc. Filed: 2025-07-16 AccNo: 0001950047-25-005055 Size: 15 KB

New Form 4 - Inspire Medical Systems, Inc. Filed: 2025-07-16 AccNo: 0001104659-25-068328 Size: 6 KB

New Form SC 14D9 - IGM Biosciences, Inc. Filed: 2025-07-16 AccNo: 0001193125-25-159860 Size: 475 KB

New Form 144 - INCYTE CORP Filed: 2025-07-16 AccNo: 0001950047-25-005053 Size: 7 KB

Viking Therapeutics to Report Financial Results for Second Quarter 2025 on July 23, 2025

New Form 4 - Inspire Medical Systems, Inc. Filed: 2025-07-16 AccNo: 0001104659-25-068327 Size: 4 KB

New Form 8-K/A - electroCore, Inc. Filed: 2025-07-16 AccNo: 0001641172-25-019883 Size: 210 KB Item 9.01: Financial Statements and Exhibits

New Form 144 - INCYTE CORP Filed: 2025-07-16 AccNo: 0001950047-25-005052 Size: 7 KB

New Form 8-K/A - Biofrontera Inc. Filed: 2025-07-16 AccNo: 0001641172-25-019884 Size: 432 KB Item 9.01: Financial Statements and Exhibits